Stock MRK MERCK & CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse
Other stock markets
 04:00:02 2024-06-07 pm EDT 		5-day change 1st Jan Change
130.7 USD +0.11% Intraday chart for Merck & Co., Inc. +4.09% +19.86%
Jun. 05 HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating MT
Jun. 04 Transcript : Merck & Co., Inc. Presents at 2024 American Society of Clinical Oncology Annual Meeting, Jun-03-2024 06:00 PM

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating
MT
Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
BU
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors
AQ
Transcript : Merck & Co., Inc. Presents at 2024 American Society of Clinical Oncology Annual Meeting, Jun-03-2024 06:00 PM
Merck: promising results in melanoma treatment
CF
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial
DJ
Moderna, Merck Say 3-Year Data for Melanoma Combination Therapy Show Continued Improvement in Recurrence-Free Survival
MT
Moderna & Merck Announces 3-Year Data for mRNA-4157 in Combination with KEYTRUDA (Pembrolizumab)
CI
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
RE
Immutep, Merck Collaborate on Trial for Lung Cancer Therapy
MT
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
RE
Sector Update: Health Care
MT
Declaration of Voting Results by Merck & Co
CI
Declaration of Voting Results by Merck & Co
CI
Declaration of Voting Results by Merck & Co
CI
Declaration of Voting Results by Merck & Co
CI
US Equities Markets Close Lower Thursday After Q1 Economic Growth Found to be Slower Than Projected
MT
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar
MT
Summit Therapeutics Shares Triple After Drug Candidate Data
DJ
Summit Therapeutics cancer therapy succeeds in late-stage China study
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck & Co., Inc.